Search Results - "Kondo, Naoya"

Refine Results
  1. 1

    A Red-Emitting Fluorescence Sensor for Detecting Boronic Acid-Containing Agents in Cells by Kondo, Naoya, Aoki, Erika, Takada, Shinya, Temma, Takashi

    Published in Sensors (Basel, Switzerland) (10-10-2022)
    “…The amount and localization of boron-10 atoms delivered into tumor cells determines the therapeutic effect of boron neutron capture therapy (BNCT) and,…”
    Get full text
    Journal Article
  2. 2

    Development of a switching-type fluorescence sensor for the detection of boronic acid-containing agents by Takada, Shinya, Kondo, Naoya, Hagimori, Masayori, Temma, Takashi

    Published in Analytical sciences (01-10-2022)
    “…Since the therapeutic effect of boron neutron capture therapy is influenced by the intracellular distribution profile of boronoagents containing 10 B atoms, it…”
    Get full text
    Journal Article
  3. 3

    Evaluation of 3-Borono-l-Phenylalanine as a Water-Soluble Boron Neutron Capture Therapy Agent by Kondo, Naoya, Hirano, Fuko, Temma, Takashi

    Published in Pharmaceutics (22-05-2022)
    “…Although 4-borono-l-phenylalanine (4-BPA) is currently the only marketed agent available for boron neutron capture therapy (BNCT), its low water solubility…”
    Get full text
    Journal Article
  4. 4

    Development of a 2-(2-Hydroxyphenyl)-1H-benzimidazole-Based Fluorescence Sensor Targeting Boronic Acids for Versatile Application in Boron Neutron Capture Therapy by Kondo, Naoya, Takada, Shinya, Hagimori, Masayori, Temma, Takashi

    Published in Cancers (20-03-2023)
    “…Boron neutron capture therapy (BNCT) is an attractive approach to treating cancers. Currently, only one 10B-labeled boronoagent (Borofalan, BPA) has been…”
    Get full text
    Journal Article
  5. 5

    Development of radioiodinated pyrimidinopyridone derivatives as targeted imaging probes of activated p38α for single photon emission computed tomography by Hashimoto, Tomoyuki, Kondo, Naoya, Hirata, Masahiko, Temma, Takashi

    Published in Annals of nuclear medicine (01-12-2021)
    “…Objective p38α, a member of the mitogen-activated protein kinase superfamily, is ubiquitously expressed in a variety of mammalian cells. Activated p38α induces…”
    Get full text
    Journal Article
  6. 6

    Indirectly radioiodinated exendin-4 as an analytical tool for in vivo detection of glucagon-like peptide-1 receptor in a disease setting by Kondo, Naoya, Oishi, Ayaka, Hirata, Masahiko, Temma, Takashi

    Published in Annals of nuclear medicine (01-01-2021)
    “…Objective Glucagon-like peptide-1 receptor agonist (GLP-1RA) has been reported to have therapeutic effects on diabetes and various diseases. Precise detection…”
    Get full text
    Journal Article
  7. 7

    Radiobrominated probe targeting activated p38α in inflammatory diseases by Hashimoto, Tomoyuki, Kondo, Naoya, Makino, Akira, Kiyono, Yasushi, Temma, Takashi

    Published in Annals of nuclear medicine (01-10-2022)
    “…Objective p38α, a member of the mitogen-activated protein kinase superfamily, is activated by external stimuli, followed by nuclear translocation for the…”
    Get full text
    Journal Article
  8. 8

    A report of three cases of patients with tubulointerstitial nephritis with IgM-positive plasma cells, treatment, and serum-IgM as a sensitive marker for relapse by Akagi, Ryota, Ishii, Akira, Kaneko, Keiichi, Kondo, Naoya, Yokoi, Hideki, Matsubara, Takeshi, Minamiguchi, Sachiko, Kanno, Yoshihiko, Yanagita, Motoko

    Published in BMC nephrology (04-07-2023)
    “…Tubulointerstitial nephritis with IgM-positive plasma cells (IgMPC-TIN) is a newer disease about which there are many unclear points. Glucocorticoid therapy is…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Radioiodinated Peptidic Imaging Probes for in Vivo Detection of Membrane Type-1 Matrix Metalloproteinase in Cancers by Kondo, Naoya, Temma, Takashi, Shimizu, Yoichi, Ono, Masahiro, Saji, Hideo

    “…Membrane type-1 matrix metalloproteinase (MT1-MMP) plays pivotal roles in tumor progression and metastasis, and holds great promise as an early biomarker for…”
    Get full text
    Journal Article
  11. 11

    Synthesis and evaluation of [18F]FBNAF, a STAT3-targeting probe, for PET imaging of tumor microenvironment by Miyazaki, Anna, Kanai, Yasukazu, Wakamori, Keita, Mizuguchi, Serina, Futatsugi, Mikiya, Hirano, Fuko, Kondo, Naoya, Temma, Takashi

    Published in EJNMMI radiopharmacy and chemistry (04-06-2024)
    “…Background Signal transducer and activator of transcription 3 (STAT3) is a protein that regulates cell proliferation and differentiation, and it is attracting…”
    Get full text
    Journal Article
  12. 12

    疾患におけるマトリックスメタロプロテアーゼ発現のインビボ定量法構築を目的とした核医学イメージングプローブの開発 by 近藤, 直哉

    Published in YAKUGAKU ZASSHI (01-01-2020)
    “…「1. はじめに」マトリックスメタロプロテアーゼ(matrix metalloproteinase; MMP)は主に細胞外マトリックス分解に関与する酵素であり, 種々の炎症性疾患において, その発現・活性の重症度との相関性や, 治療標的としての有効性が数多く報告されている. したがって,…”
    Get full text
    Journal Article
  13. 13

    Acetaminophen administration and the risk of acute kidney injury: a self-controlled case series study by Hiragi, Shusuke, Yamada, Hiroyuki, Tsukamoto, Tatsuo, Yoshida, Kazuki, Kondo, Naoya, Matsubara, Takeshi, Yanagita, Motoko, Tamura, Hiroshi, Kuroda, Tomohiro

    Published in Clinical epidemiology (01-01-2018)
    “…Acetaminophen (APAP) is frequently used for analgesia and is considered safer than nonsteroidal anti-inflammatory drugs (NSAIDs) for the kidneys. However,…”
    Get full text
    Journal Article
  14. 14

    Miniaturized antibodies for imaging membrane type‐1 matrix metalloproteinase in cancers by Kondo, Naoya, Temma, Takashi, Shimizu, Yoichi, Watanabe, Hiroyuki, Higano, Keiichi, Takagi, Yoko, Ono, Masahiro, Saji, Hideo

    Published in Cancer science (01-04-2013)
    “…Since membrane type‐1 matrix metalloproteinase (MT1‐MMP) plays pivotal roles in tumor progression and metastasis and holds great promise as an early biomarker…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Investigation of a MMP-2 activity-dependent anchoring probe for nuclear imaging of cancer by Temma, Takashi, Hanaoka, Hirofumi, Yonezawa, Aki, Kondo, Naoya, Sano, Kohei, Sakamoto, Takeharu, Seiki, Motoharu, Ono, Masahiro, Saji, Hideo

    Published in PloS one (10-07-2014)
    “…Since matrix metalloproteinase-2 (MMP-2) is an important marker of tumor malignancy, we developed an original drug design strategy, MMP-2 activity dependent…”
    Get full text
    Journal Article
  18. 18

    Long-term survival and renal dysfunction in a patient with recurrent colorectal cancer treated with Bevacizumab by Kataoka, Shigeki, Nishikawa, Yoshitaka, Funakoshi, Taro, Horimatsu, Takahiro, Kondo, Naoya, Matsubara, Takeshi, Yanagita, Motoko, Matsumoto, Shigemi, Muto, Manabu

    Published in Clinical journal of gastroenterology (01-06-2020)
    “…Advances in cancer chemotherapy have increased the opportunities of treating patients with cancer with renal dysfunction. Here we report the case of a…”
    Get full text
    Journal Article
  19. 19

    Comparison of 125I- and 111In-labeled peptide probes for in vivo detection of oxidized low-density lipoprotein in atherosclerotic plaques by Temma, Takashi, Kondo, Naoya, Yoda, Keiko, Nishigori, Kantaro, Onoe, Satoru, Shiomi, Masashi, Ono, Masahiro, Saji, Hideo

    Published in Annals of nuclear medicine (01-07-2018)
    “…Objective Oxidized low-density lipoprotein (OxLDL) plays a pivotal role in atherosclerotic plaque destabilization, which suggests its potential as a nuclear…”
    Get full text
    Journal Article
  20. 20

    In vivo imaging of membrane type‐1 matrix metalloproteinase with a novel activatable near‐infrared fluorescence probe by Shimizu, Yoichi, Temma, Takashi, Hara, Isao, Makino, Akira, Kondo, Naoya, Ozeki, Ei‐ichi, Ono, Masahiro, Saji, Hideo

    Published in Cancer science (01-08-2014)
    “…Membrane type‐1 matrix metalloproteinase (MT1‐MMP) is a protease activating MMP‐2 that mediates cleavage of extracellular matrix components and plays pivotal…”
    Get full text
    Journal Article